Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatment
dc.contributor.author | Greig, Nigel H. | |
dc.contributor.author | Sambamurti, Kumar | |
dc.contributor.author | Lahiri, Debomoy K. | |
dc.contributor.author | Becker, Robert E. | |
dc.contributor.department | Department of Psychiatry, IU School of Medicine | en_US |
dc.date.accessioned | 2017-06-12T14:31:49Z | |
dc.date.available | 2017-06-12T14:31:49Z | |
dc.date.issued | 2014-10 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Greig, N. H., Sambamurti, K., Lahiri, D. K., & Becker, R. E. (2014). Amyloid precursor protein synthesis inhibitors for Alzheimer’s disease treatment. Annals of Neurology, 76(4), 629–630. http://doi.org/10.1002/ana.24254 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/12957 | |
dc.language.iso | en_US | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/ana.24254 | en_US |
dc.relation.journal | Annals of Neurology | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Amyloid beta-Protein Precursor -- Genetics | en_US |
dc.subject | Amyloid beta-Protein Precursor -- Metabolism | en_US |
dc.subject | Animals | en_US |
dc.subject | Female | en_US |
dc.subject | Gene Expression Regulation | en_US |
dc.subject | Humans | en_US |
dc.subject | Plaque, Amyloid -- Prevention & control | en_US |
dc.title | Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatment | en_US |
dc.type | Article | en_US |